PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Lobbying client · District of Columbia · filed 2025 to 2026

Trade association representing the nation's leading biopharmaceutical research companies.

$210,000 Reported spend

6 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (58100), not by name.

Firms hired 1

YC CONSULTING, LLC $210,000 6 filings

Bills named in these filings 3

HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…

4 filings
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2 filings
HR 3269
ETHIC Act

2 filings

Reported by year 2 years

2026 $90,000 2 filings
2025 $120,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 6
Office of Management & Budget (OMB) 2
Labor, Dept of (DOL) 1

Recent filings 6 total

Q2

YC CONSULTING, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · $60,000 income · posted Jul 7, 2026

View → Q1

YC CONSULTING, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · $30,000 income · posted Apr 6, 2026

View → Q4

YC CONSULTING, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · $30,000 income · posted Jan 20, 2026

View → Q3

YC CONSULTING, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · $30,000 income · posted Oct 20, 2025

View → Q2

YC CONSULTING, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · $30,000 income · posted Jul 24, 2025

View → Q1

YC CONSULTING, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · $30,000 income · posted Apr 20, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.